Product Name
Filamin A Alpha (FLNa), Polyclonal Antibody
Full Product Name
Polyclonal Antibody to Filamin A Alpha (FLNa)
Product Gene Name
anti-FLNa antibody
[Similar Products]
Matching Pairs
Unconjugated Antibody: Filamin A Alpha (MBS2028012)
Immunogen: Filamin A Alpha (MBS2030753)
Matching Pairs
Unconjugated Antibody: Filamin A Alpha (MBS2028012)
APC-CY7 Conjugated Antibody: Filamin A Alpha (FLNa) (MBS2064038)
Matching Pairs
Unconjugated Antibody: Filamin A Alpha (MBS2028012)
PE Conjugated Antibody: Filamin A Alpha (FLNa) (MBS2064039)
Matching Pairs
Unconjugated Antibody: Filamin A Alpha (MBS2028012)
APC Conjugated Antibody: Filamin A Alpha (FLNa) (MBS2064040)
Matching Pairs
Unconjugated Antibody: Filamin A Alpha (MBS2028012)
Cy3 Conjugated Antibody: Filamin A Alpha (FLNa) (MBS2064041)
Matching Pairs
Unconjugated Antibody: Filamin A Alpha (MBS2028012)
FITC Conjugated Antibody: Filamin A Alpha (FLNa) (MBS2064042)
Matching Pairs
Unconjugated Antibody: Filamin A Alpha (MBS2028012)
HRP Conjugated Antibody: Filamin A Alpha (FLNa) (MBS2064043)
Matching Pairs
Unconjugated Antibody: Filamin A Alpha (MBS2028012)
APC-CY7 Conjugated Secondary Antibody: Immunoglobulin G (MBS2090675)
Matching Pairs
Unconjugated Antibody: Filamin A Alpha (MBS2028012)
Unconjugated Secondary Antibody: Immunoglobulin G (MBS2090678)
Matching Pairs
Unconjugated Antibody: Filamin A Alpha (MBS2028012)
Biotin Conjugated Antibody: Filamin A Alpha (FLNa) (MBS2090684)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Immunogen Sequence
Antigen: The target protein is fused with two N-terminal Tags, His-tag and T7-tag and its sequence is listed below.
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEF- SSSHSRAGQ SAAGAAPGGG VDTRDAEMPA TEKDLAEDAP WKKIQQNTFT RWCNEHLKCV SKRIANLQTD LSDGLRLIAL LEVLSQKKMH RKHNQRPTFR QMQLENVSVA LEFLDRESIK LVSIDSKAIV DGNLKLILGL IWTLILHYSI SMPMWDEEED EEAKKQTPKQ RLLGWIQNKL PQLPITNFSR DWQSGRALGA LVDSCAPGLC PDWDSWDASK PVTNAREAMQ QADDWLGIPQ VITPEEIVDP NVDEHSVMTY
3D Structure
ModBase 3D Structure for P21333
Specificity
The antibody is a rabbit polyclonal antibody raised against FLNa. It has beenselected for its ability to recognize FLNa in immunohistochemical staining andwestern blotting.
Purity/Purification
Affinity Chromatography
Concentration
200ug/ml (lot specific)
Fragment
FLNa (Ser2~Pro274)
Organism Species
Homo sapiens (Human)
Immunogen
Recombinant FLNa (Ser2~Pro274) expressed in E Coli.
Conjugated Antibody
The APC conjugated antibody version of this item is also available as catalog #MBS2064040
Preparation and Storage
Store at 4 degree C for frequent use. Stored at -20 degree C to -80 degree C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
ISO Certification
Manufactured in an ISO 9001:2008 and ISO 13485:2003 Certified Laboratory.
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customerâs specifications, please inquire.
Other Notes
Small volumes of anti-FLNa antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Applications Tested/Suitable for anti-FLNa antibody
Western Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Formalin/Paraffin, ELISA (EIA)
Application Notes for anti-FLNa antibody
Western blotting: 0.5-2ug/mL
Immunohistochemistry: 5-20ug/mL
Immunocytochemistry: 5-20ug/mL
Optimal working dilutions must be determined by end user.
Western Blot (WB) of anti-FLNa antibody
Western Blot: Sample: Recombinant FLNa, Human.

Immunohistochemistry (IHC) of anti-FLNa antibody
DAB staining on IHC-P; Samples: Human Prostate Gland Cancer Tissue

Immunohistochemistry (IHC) of anti-FLNa antibody
DAB staining on IHC-P; Samples: Human Liver Tissue.

Immunohistochemistry (IHC) of anti-FLNa antibody
DAB staining on IHC-P; Samples: Human Prostate Gland Tissue.

Immunohistochemistry (IHC) of anti-FLNa antibody
DAB staining on IHC-P; Samples: Human Stomach Tissue.

NCBI/Uniprot data below describe general gene information for FLNa. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001104026.1
[Other Products]
NCBI GenBank Nucleotide #
NM_001110556.1
[Other Products]
UniProt Primary Accession #
P21333
[Other Products]
UniProt Secondary Accession #
Q5HY53; Q5HY55; Q8NF52; E9KL45[Other Products]
UniProt Related Accession #
P21333[Other Products]
Molecular Weight
280,018 Da
NCBI Official Full Name
filamin-A isoform 2
NCBI Official Synonym Full Names
filamin A
NCBI Official Symbol
FLNA [Similar Products]
NCBI Official Synonym Symbols
FLN; FMD; MNS; OPD; ABPX; CSBS; CVD1; FLN1; NHBP; OPD1; OPD2; XLVD; XMVD; FLN-A; ABP-280
[Similar Products]
NCBI Protein Information
filamin-A
UniProt Protein Name
Filamin-A
UniProt Synonym Protein Names
Actin-binding protein 280; ABP-280; Alpha-filamin; Endothelial actin-binding protein; Filamin-1; Non-muscle filamin
UniProt Gene Name
FLNA [Similar Products]
UniProt Synonym Gene Names
FLN; FLN1; FLN-A; ABP-280 [Similar Products]
NCBI Summary for FLNa
The protein encoded by this gene is an actin-binding protein that crosslinks actin filaments and links actin filaments to membrane glycoproteins. The encoded protein is involved in remodeling the cytoskeleton to effect changes in cell shape and migration. This protein interacts with integrins, transmembrane receptor complexes, and second messengers. Defects in this gene are a cause of several syndromes, including periventricular nodular heterotopias (PVNH1, PVNH4), otopalatodigital syndromes (OPD1, OPD2), frontometaphyseal dysplasia (FMD), Melnick-Needles syndrome (MNS), and X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]
UniProt Comments for FLNa
FLNA: a ubiquitous cytoskeletal protein that promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Plays an essential role in embryonic cell migration. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interactions with filamin A may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking.
Protein type: Actin-binding; Motility/polarity/chemotaxis; Nuclear receptor co-regulator
Chromosomal Location of Human Ortholog: Xq28
Cellular Component: actin cytoskeleton; cell soma; cortical cytoskeleton; cytoplasm; cytosol; dendritic shaft; extracellular exosome; extracellular matrix; extracellular region; filamentous actin; focal adhesion; intercellular junction; membrane; nucleolus; nucleus; perinuclear region of cytoplasm; plasma membrane; Z disc
Molecular Function: actin filament binding; cadherin binding; G-protein coupled receptor binding; GTPase binding; ion channel binding; kinase binding; mu-type opioid receptor binding; potassium channel regulator activity; protein binding; protein homodimerization activity; Rac GTPase binding; Ral GTPase binding; Rho GTPase binding; RNA binding; signal transducer activity; SMAD binding; small GTPase binding; transcription factor binding
Biological Process: actin crosslink formation; actin cytoskeleton reorganization; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cerebral cortex development; cytoplasmic sequestering of protein; establishment of protein localization; formation of radial glial scaffolds; mitotic spindle assembly; mRNA transcription from RNA polymerase II promoter; negative regulation of apoptosis; negative regulation of protein catabolic process; negative regulation of transcription factor activity; negative regulation of transcription from RNA polymerase I promoter; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB signaling; positive regulation of integrin-mediated signaling pathway; positive regulation of neural precursor cell proliferation; positive regulation of neuron migration; positive regulation of potassium ion transmembrane transport; positive regulation of substrate adhesion-dependent cell spreading; positive regulation of transcription factor import into nucleus; protein localization to cell surface; protein localization to plasma membrane; protein stabilization; receptor clustering; regulation of cell migration; regulation of membrane repolarization during atrial cardiac muscle cell action potential; regulation of membrane repolarization during cardiac muscle cell action potential; semaphorin-plexin signaling pathway; wound healing, spreading of cells
Disease: Cardiac Valvular Dysplasia, X-linked; Fg Syndrome 2; Frontometaphyseal Dysplasia; Heterotopia, Periventricular, Ehlers-danlos Variant; Heterotopia, Periventricular, X-linked Dominant; Intestinal Pseudoobstruction, Neuronal, Chronic Idiopathic, X-linked; Melnick-needles Syndrome; Otopalatodigital Syndrome, Type I; Otopalatodigital Syndrome, Type Ii; Terminal Osseous Dysplasia
Research Articles on FLNa
1. FLNA is downregulated in parathyroid tumors and parallels the CASR expression levels. Loss of FLNA reduces CASR mRNA and protein expression levels and the CASR-induced ERK phosphorylation. FLNA is involved in receptor expression, membrane localization and ERK signaling activation of both 990R and 990G CASR variants.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.